Published guidance, NICE advice and quality standards | Guidance

Showing 461 to 470 of 875

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)	TA648	9 September 2020	9 September 2020
Avelumab with axitinib for untreated advanced renal cell carcinoma	TA645	2 September 2020	2 September 2020
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)	TA646	2 September 2020	2 September 2020
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal)	TA647	2 September 2020	2 September 2020
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer	TA643	12 August 2020	12 August 2020
Entrectinib for treating NTRK fusion-positive solid tumours	TA644	12 August 2020	12 August 2020
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma	TA641	12 August 2020	12 August 2020
Gilteritinib for treating relapsed or refractory acute myeloid leukaemia	TA642	12 August 2020	12 August 2020
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant	TA640	5 August 2020	5 August 2020
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer	TA638	1 July 2020	1 July 2020